ReviewJournal of hematology & oncology2023

Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents.

Neeraj Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.